Lifeward

Lifeward EBITDA Margin

The EBITDA Margin of Lifeward (LFWD) as of Nov 22, 2026 is -88.64 %. In the previous year, EBITDA Margin was -76.19 % — a change of 16.34% (lower).

EBITDA Margin

-88.64 %

YoY

16.34%

Last updated:

EBITDA Margin of Lifeward is 2025 -88.64 % . EBITDA Margin of Lifeward was 2024 -76.19 % . It decreases by 16.34% lower compared to the previous year.

The Lifeward EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
-293.57 USD
Jan 1, 2019
-288.28 USD
Jan 1, 2020
-273.57 USD
Jan 1, 2021
-212.12 USD
Jan 1, 2022
-346.62 USD
Jan 1, 2023
-170.43 USD
Jan 1, 2024
-76.19 USD
Jan 1, 2025
-88.64 USD
The Lifeward EBITDA Margin history
YEAREBITDA MarginYoY
-88.64 %+16.34%
-76.19 %-55.30%
-170.43 %-50.83%
-346.62 %+63.41%
-212.12 %-22.46%
-273.57 %-5.10%
-288.28 %-1.80%
-293.57 %+3.49%
-283.66 %-45.31%
-518.67 %-22.82%
-672.02 %+33.26%
-504.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

EBITDA Margin of Lifeward is -88.64 % in 2025.

EBITDA Margin of Lifeward changed from -76.19 % to -88.64 %, representing a 16.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Lifeward since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Lifeward with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Lifeward

All Key Metrics — Lifeward